TransMedics Expects Full-year 2024 Total Revenue Of $360M-$370M, Est $330.227M
Portfolio Pulse from Benzinga Newsdesk
TransMedics forecasts a significant revenue increase for the full year 2024, expecting total revenue to be between $360M-$370M, which surpasses the estimated $330.227M. This projection indicates a growth of 49% to 53% compared to the previous year's revenue.
February 26, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TransMedics forecasts a significant increase in revenue for 2024, expecting $360M-$370M, which is well above the estimated $330.227M. This indicates a growth of 49% to 53% from the previous year.
The significant upward revision in TransMedics' revenue forecast for 2024 suggests a strong growth trajectory and operational success. This positive outlook is likely to instill investor confidence and could lead to an increase in the stock price in the short term. The forecasted growth rate of 49% to 53% compared to the previous year highlights the company's potential for substantial revenue expansion, making this news highly relevant and important for investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100